(Q40696631)

22 September 2017

Transdominant suppression of estrogen receptor signaling by progesterone receptor ligands in uterine leiomyoma cells (English)

1 reference

22 September 2017

1 reference

Leslie C Hodges

1

1 reference

22 September 2017

Kevin D Houston

2

1 reference

22 September 2017

Deborah S Hunter

3

1 reference

22 September 2017

Robin Fuchs-Young

4

1 reference

22 September 2017

Zhiming Zhang

5

1 reference

22 September 2017

Richard C Wineker

6

1 reference

22 September 2017

Cheryl L Walker

7

1 reference

22 September 2017

1 October 2002

1 reference

Molecular and Cellular Endocrinology

22 September 2017

1 reference

22 September 2017

196

1 reference

22 September 2017

1-2

1 reference

22 September 2017

11-20

1 reference

Growth factors and cytokines in uterine leiomyomas

22 September 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0303-7207%2802%2900230-7

7 January 2021

Abnormal gene expression in uterine leiomyomas

1 reference

https://api.crossref.org/works/10.1016%2FS0303-7207%2802%2900230-7

7 January 2021

Leiomyoma primary cultures have elevated transcriptional response to estrogen compared with autologous myometrial cultures

1 reference

https://api.crossref.org/works/10.1016%2FS0303-7207%2802%2900230-7

7 January 2021

Growth stimulation of T47D human breast cancer cells by the anti-progestin RU486.

1 reference

https://api.crossref.org/works/10.1016%2FS0303-7207%2802%2900230-7

7 January 2021

Seasonal changes in the molecular species and nuclear binding of the chick oviduct progesterone receptor

1 reference

https://api.crossref.org/works/10.1016%2FS0303-7207%2802%2900230-7

7 January 2021

Progesterone receptor messenger ribonucleic acid and protein are overexpressed in human uterine leiomyomas

1 reference

https://api.crossref.org/works/10.1016%2FS0303-7207%2802%2900230-7

7 January 2021

Altered hormonal responsiveness of proliferation and apoptosis during myometrial maturation and the development of uterine leiomyomas in the rat.

1 reference

https://api.crossref.org/works/10.1016%2FS0303-7207%2802%2900230-7

7 January 2021

Dysregulation of IGF-I signaling in uterine leiomyoma

1 reference

https://api.crossref.org/works/10.1016%2FS0303-7207%2802%2900230-7

7 January 2021

The frequency of uterine leiomyomas

1 reference

https://api.crossref.org/works/10.1016%2FS0303-7207%2802%2900230-7

7 January 2021

Novel mechanisms of progesterone antagonists and progesterone receptor

1 reference

https://api.crossref.org/works/10.1016%2FS0303-7207%2802%2900230-7

7 January 2021

Sex steroid receptors in human myometrium and fibroids: changes during the menstrual cycle and gonadotropin-releasing hormone treatment.

1 reference

https://api.crossref.org/works/10.1016%2FS0303-7207%2802%2900230-7

7 January 2021

Progestin-mediated changes in progesterone receptor forms in the normal human endometrium

1 reference

https://api.crossref.org/works/10.1016%2FS0303-7207%2802%2900230-7

7 January 2021

Inhibition of estrogen-stimulated growth of uterine leiomyomas by selective estrogen receptor modulators

1 reference

https://api.crossref.org/works/10.1016%2FS0303-7207%2802%2900230-7

7 January 2021

Expression of progesterone receptor form A and B mRNAs in uterine leiomyoma

1 reference

https://api.crossref.org/works/10.1016%2FS0303-7207%2802%2900230-7

7 January 2021

Estrogenic effects of organochlorine pesticides on uterine leiomyoma cells in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS0303-7207%2802%2900230-7

7 January 2021

Estrogen/antiestrogen responsiveness in an in vivo/in vitro model for myometrial tumorigenesis

1 reference

https://api.crossref.org/works/10.1016%2FS0303-7207%2802%2900230-7

7 January 2021

Mechanisms of action and cross-talk between estrogen receptor and progesterone receptor pathways

1 reference

https://api.crossref.org/works/10.1016%2FS0303-7207%2802%2900230-7

7 January 2021

Mitotic activity in uterine leiomyomas during the menstrual cycle

1 reference

https://api.crossref.org/works/10.1016%2FS0303-7207%2802%2900230-7

7 January 2021

Clinical efficacy of the antiprogesterone RU486 in the treatment of endometriosis and uterine fibroids

1 reference

https://api.crossref.org/works/10.1016%2FS0303-7207%2802%2900230-7

7 January 2021

Identification of multiple, widely spaced estrogen-responsive regions in the rat progesterone receptor gene

1 reference

https://api.crossref.org/works/10.1016%2FS0303-7207%2802%2900230-7

7 January 2021

Inhibitory cross-talk between steroid hormone receptors: differential targeting of estrogen receptor in the repression of its transcriptional activity by agonist- and antagonist-occupied progestin receptors

1 reference

https://api.crossref.org/works/10.1016%2FS0303-7207%2802%2900230-7

7 January 2021

Calbindin-D9k gene expression in the uterus: study of the two messenger ribonucleic acid species and analysis of an imperfect estrogen- responsive element

1 reference

https://api.crossref.org/works/10.1016%2FS0303-7207%2802%2900230-7

7 January 2021

Immunohistochemical analysis of human uterine estrogen and progesterone receptors throughout the menstrual cycle

1 reference

https://api.crossref.org/works/10.1016%2FS0303-7207%2802%2900230-7

7 January 2021

Chronological Changes in Sex Steroid, Gonadotropin and Prolactin Secretion in Aging Female Rats Displaying Different Reproductive States1

1 reference

https://api.crossref.org/works/10.1016%2FS0303-7207%2802%2900230-7

7 January 2021

Differential expression of uterine progesterone receptor forms A and B during the menstrual cycle

1 reference

https://api.crossref.org/works/10.1016%2FS0303-7207%2802%2900230-7

7 January 2021

Immunohistochemical study of the proliferation index, oestrogen receptors and progesterone receptors A and B in leiomyomata and normal myometrium during the menstrual cycle and under gonadotrophin-releasing hormone agonist therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0303-7207%2802%2900230-7

7 January 2021

Differential ligand activation of estrogen receptors ERalpha and ERbeta at AP1 sites

1 reference

https://api.crossref.org/works/10.1016%2FS0303-7207%2802%2900230-7

7 January 2021

Fibroid and myometrial steroid receptors in women treated with gonadotropin-releasing hormone agonist leuprolide acetate.

1 reference

https://api.crossref.org/works/10.1016%2FS0303-7207%2802%2900230-7

7 January 2021

Progesterone: a critical role in the pathogenesis of uterine myomas

1 reference

https://api.crossref.org/works/10.1016%2FS0303-7207%2802%2900230-7

7 January 2021

Estradiol-dependent uterine leiomyomas in transgenic mice

1 reference

https://api.crossref.org/works/10.1016%2FS0303-7207%2802%2900230-7

7 January 2021

Murine progesterone receptor exists predominantly as the 83-kilodalton 'A' form

1 reference

https://api.crossref.org/works/10.1016%2FS0303-7207%2802%2900230-7

7 January 2021

Up-regulation by progesterone of proliferating cell nuclear antigen and epidermal growth factor expression in human uterine leiomyoma.

1 reference

https://api.crossref.org/works/10.1016%2FS0303-7207%2802%2900230-7

7 January 2021

RU486 suppresses prolactin production in explant cultures of leiomyoma and myometrium

1 reference

https://api.crossref.org/works/10.1016%2FS0303-7207%2802%2900230-7

7 January 2021

Distribution of the A and B forms of the progesterone receptor messenger ribonucleic acid and protein in uterine leiomyomata and adjacent myometrium

1 reference

https://api.crossref.org/works/10.1016%2FS0303-7207%2802%2900230-7

7 January 2021

Tamoxifen activation of the estrogen receptor/AP-1 pathway: potential origin for the cell-specific estrogen-like effects of antiestrogens

1 reference

https://api.crossref.org/works/10.1016%2FS0303-7207%2802%2900230-7

7 January 2021

The A and B isoforms of the human progesterone receptor operate through distinct signaling pathways within target cells

1 reference

https://api.crossref.org/works/10.1016%2FS0303-7207%2802%2900230-7

7 January 2021

10.1016/S0303-7207(02)00230-7

Identifiers

DOI

1 reference

22 September 2017

1 reference